Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Strumane

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Enzymology|June 8, 2006
The Rac activator Tiam1 and Ras-induced oncogenesisKristin Strumane, Tomasz P Rygiel, John G Collard
Leukemia Research|May 25, 2007
Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiencyKristin Strumane, Ji-Ying Song, Inge Baas, et al.
Journal of Cell Science|March 20, 2008
The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylationTomasz P Rygiel, Alexander E Mertens, Kristin Strumane, et al.
Molecular Immunology|February 21, 2015
Complement in therapy and disease: Regulating the complement system with antibody-based therapeuticsJoost P M Melis, Kristin Strumane, Sigrid R Ruuls, et al.
BMC Genomics|March 17, 2004
Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA ampliconsKatleen De Preter, Filip Pattyn, Geert Berx, et al.
Cancer Research|October 19, 2006
E-cadherin regulates human Nanos1, which interacts with p120ctn and induces tumor cell migration and invasionKristin Strumane, Arnaud Bonnomet, Christophe Stove, et al.
Mabs|February 5, 2014
HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate designBart E C G de Goeij, Matthias Peipp, Simone de Haij, et al.
Plos Biology|January 7, 2016
A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell SurfaceRob N de Jong, Frank J Beurskens, Sandra Verploegen, et al.
Molecular Cancer Therapeutics|August 28, 2020
Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 AgonismMarije B Overdijk, Kristin Strumane, Frank J Beurskens, et al.
Clinical and Translational Science|May 23, 2026
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed HepatotoxicityMarije B Overdijk, Kristin Strumane, Ruth Plummer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Enzymology|June 8, 2006
The Rac activator Tiam1 and Ras-induced oncogenesisKristin Strumane, Tomasz P Rygiel, John G Collard
Leukemia Research|May 25, 2007
Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiencyKristin Strumane, Ji-Ying Song, Inge Baas, et al.
Journal of Cell Science|March 20, 2008
The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylationTomasz P Rygiel, Alexander E Mertens, Kristin Strumane, et al.
Molecular Immunology|February 21, 2015
Complement in therapy and disease: Regulating the complement system with antibody-based therapeuticsJoost P M Melis, Kristin Strumane, Sigrid R Ruuls, et al.
BMC Genomics|March 17, 2004
Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA ampliconsKatleen De Preter, Filip Pattyn, Geert Berx, et al.
Cancer Research|October 19, 2006
E-cadherin regulates human Nanos1, which interacts with p120ctn and induces tumor cell migration and invasionKristin Strumane, Arnaud Bonnomet, Christophe Stove, et al.
Mabs|February 5, 2014
HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate designBart E C G de Goeij, Matthias Peipp, Simone de Haij, et al.
Plos Biology|January 7, 2016
A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell SurfaceRob N de Jong, Frank J Beurskens, Sandra Verploegen, et al.
Molecular Cancer Therapeutics|August 28, 2020
Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 AgonismMarije B Overdijk, Kristin Strumane, Frank J Beurskens, et al.
Clinical and Translational Science|May 23, 2026
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed HepatotoxicityMarije B Overdijk, Kristin Strumane, Ruth Plummer, et al.
Pageof 2